Skip to main content
Premium Trial:

Request an Annual Quote

Katherine Andrews-Cramer, Dave Oehler

Premium

Integrated Genomics has hired Katherine Andrews-Cramer as director of business development and Dave Oehler as director of marketing and sales. Andrews-Cramer was most recently vice president of business development of Argenta Discovery. Prior to that, she was director of business development at Advanced SynTech and director of biology for Cytoprint. She has also held positions at Phase-1 Molecular Toxicology, Ciphergen Biosystems, and Tripos. Oehler was most recently director of sales for Hitachi’s MiraiBio subsidiary. Before joining MiraiBio, he was a Midwest region sales representative for Novex.

Filed under

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.